Geode Capital Management, LLC Relmada Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 302,354 shares of RLMD stock, worth $483,766. This represents 0.0% of its overall portfolio holdings.

Number of Shares

302,354

Previous 301,883 0.16%

Holding current value

$483,766

Previous $81,000 123.46%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$0.25 - $0.83 $117 - $390	471 Added 0.16%	302,354 $181,000
Q1 2025 May 13, 2025	SELL	$0.26 - $0.47 $248 - $448	-955 Reduced 0.32%	301,883 $81,000
Q4 2024 Feb 12, 2025	SELL	$0.35 - $3.65 $582 - $6,073	-1,664 Reduced 0.55%	302,838 $157,000
Q3 2024 Nov 12, 2024	BUY	$2.3 - $4.36 $101,209 - $191,857	44,004 Added 16.89%	304,502 $986,000
Q2 2024 Aug 09, 2024	BUY	$2.93 - $4.94 $12,924 - $21,790	4,411 Added 1.72%	260,498 $781,000
Q1 2024 May 13, 2024	BUY	$3.1 - $6.8 $39,289 - $86,183	12,674 Added 5.21%	256,087 $1.19 Million
Q4 2023 Feb 13, 2024	BUY	$2.45 - $4.22 $8,597 - $14,807	3,509 Added 1.46%	243,413 $1.01 Million
Q3 2023 Nov 13, 2023	BUY	$2.48 - $3.79 $13,744 - $21,004	5,542 Added 2.36%	239,904 $719,000
Q2 2023 Aug 11, 2023	SELL	$2.22 - $3.54 $594,917 - $948,652	-267,981 Reduced 53.35%	234,362 $576,000
Q1 2023 May 15, 2023	BUY	$2.24 - $4.76 $36,046 - $76,597	16,092 Added 3.31%	502,343 $1.14 Million
Q4 2022 Feb 13, 2023	SELL	$2.17 - $35.84 $9,897 - $163,466	-4,561 Reduced 0.93%	486,251 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $119,224 - $241,185	-6,515 Reduced 1.31%	490,812 $18.2 Million
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $699,979 - $1.29 Million	42,423 Added 9.33%	497,327 $9.44 Million
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $1.86 Million - $2.99 Million	110,947 Added 32.26%	454,904 $12.3 Million
Q4 2021 Feb 11, 2022	BUY	$16.93 - $26.82 $1.53 Million - $2.42 Million	90,254 Added 35.57%	343,957 $7.75 Million
Q3 2021 Nov 12, 2021	BUY	$21.86 - $34.77 $204,850 - $325,829	9,371 Added 3.84%	253,703 $6.65 Million
Q2 2021 Aug 13, 2021	BUY	$29.55 - $39.15 $149,523 - $198,099	5,060 Added 2.11%	244,332 $7.82 Million
Q1 2021 May 12, 2021	BUY	$31.52 - $39.28 $1.06 Million - $1.32 Million	33,585 Added 16.33%	239,272 $8.42 Million
Q4 2020 Feb 12, 2021	BUY	$29.88 - $39.8 $162,457 - $216,392	5,437 Added 2.72%	205,687 $6.6 Million
Q3 2020 Nov 13, 2020	BUY	$34.42 - $43.78 $69,080 - $87,866	2,007 Added 1.01%	200,250 $7.53 Million
Q2 2020 Aug 13, 2020	BUY	$31.59 - $49.98 $2.86 Million - $4.53 Million	90,554 Added 84.09%	198,243 $8.87 Million
Q1 2020 May 14, 2020	BUY	$23.78 - $50.12 $251,616 - $530,319	10,581 Added 10.9%	107,689 $3.67 Million
Q4 2019 Feb 13, 2020	BUY	$10.1 - $47.18 $980,790 - $4.58 Million	97,108 New	97,108 $3.79 Million

Others Institutions Holding RLMD

# of Institutions

Shares Held

5.43M

Call Options Held

Put Options Held

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $45.8M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Relmada Therapeutics, Inc. Transaction History